lymphocyte

(redirected from Tumor-Infiltrating Lymphocyte)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.

lymphocyte:

see bloodblood,
fluid pumped by the heart that circulates throughout the body via the arteries, veins, and capillaries (see circulatory system; heart). An adult male of average size normally has about 6 quarts (5.6 liters) of blood.
..... Click the link for more information.
; immunityimmunity,
ability of an organism to resist disease by identifying and destroying foreign substances or organisms. Although all animals have some immune capabilities, little is known about nonmammalian immunity.
..... Click the link for more information.
.

lymphocyte

[′lim·fə‚sīt]
(histology)
An agranular leukocyte formed primarily in lymphoid tissue; occurs as the principal cell type of lymph and composes 20-30% of the blood leukocytes.

lymphocyte

a type of white blood cell formed in lymphoid tissue
References in periodicals archive ?
On the other hand, CEACAM1 expression modulates melanoma cell escape from immunologic attacks; when melanoma cells and tumor-infiltrating lymphocytes are coincubated in vitro, surviving melanoma cells increase CEACAM1 expression, which is dependent on constant presence of interferon gamma.
In this study, we showed that the presence of large numbers of tumor-infiltrating lymphocytes was inversely correlated with the incidence of nodal metastasis in our cohort of patients with oropharyngeal squamous cell carcinoma, particularly those who were HPV-positive.
59) We have also used IA in an on-slide "flow cytometry"-type approach to quantitate inflammatory cells in autoimmune pancreatitis, (39) and it is possible that such methods may become important in quantitating inflammatory cells in a variety of applications (eg, tumor-infiltrating lymphocytes in gastrointestinal tract cancers).
Prior research had shown that human melanoma tumors often contain mutation-reactive immune cells called tumor-infiltrating lymphocytes (TILs).
Several weeks ago, the researchers removed white blood cells called tumor-infiltrating lymphocytes from each patient's tumors.
NEW HISTOPATHOLOGIC THERANOSTIC MARKERS: TUMOR-INFILTRATING LYMPHOCYTES
The company's lead product candidate, LN-144, is reportedly an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) for the treatment of patients with refractory metastatic melanoma, and is based on a clinical Cooperative Research and Development Agreement with the National Cancer Institute.
These cells, called tumor-infiltrating lymphocytes (TIL), home in on and destroy tumors.
The company stated that the license is based on two provisional patent applications, filed under 'Compositions and Methods for Improving Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.
The hope is that the secretion of cytokines would stimulate a tumor-specific immune response resulting in tumor destruction at other sites or would allow the collection of tumor-infiltrating lymphocytes from adjacent lymphoid tissue.

Full browser ?